Psychedelic and ketamine research trials in Taiwan
Data as of 11 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.
5 registered studies are counted in Taiwan. By compound: 5 ketamine. By registry status: 1 recruiting, 2 completed and 2 status not reported. By phase: 1 phase 2, 1 phase 3, 2 phase 4 and 1 not applicable. Reported start years run from 2015 (earliest) to 2026 (latest). Studies are linked to 4 institutions.
Country is taken from the research site linked to each registry record. A study counts once, and a study tagged with more than one compound is counted under each compound. Ketamine studies are counted only when PsychoactiveMap classifies them as psychiatric research; anaesthesia, sedation and pain studies are left out.
Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.
Recruiting now
1 of the 5 counted studies is listed in the registry as recruiting (1) or not yet recruiting (0), newest start first. Status is reported by study teams and can be out of date. PsychoactiveMap does not recruit, screen or refer anyone; eligibility and contact details are on each registry record.
| Title as registered | Registry ID | Status | Phase | Start | Institution and city |
|---|---|---|---|---|---|
| A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression | NCT07716098 | Recruiting | Phase 3 | 2026-08-03 | Janssen Research & Development, LLC, Taipei |
At a glance
- 5 registered studies are counted on this page.
By compound
| Compound hub | Studies |
|---|---|
| Ketamine | 5 |
By registry status
| Status | Studies | Share |
|---|---|---|
| Recruiting | 1 | 20% |
| Completed | 2 | 40% |
| Status not reported | 2 | 40% |
By phase
| Phase | Studies | Share |
|---|---|---|
| Phase 2 | 1 | 20% |
| Phase 3 | 1 | 20% |
| Phase 4 | 2 | 40% |
| Not applicable | 1 | 20% |
When studies started
| Start year | Studies |
|---|---|
| 2024 to 2026 | 1 |
| 2020 to 2023 | 1 |
| 2015 to 2019 | 3 |
All counted studies
All 5 counted studies, newest start first. The order is not a ranking and says nothing about quality. Titles are quoted from the registry. Each ID links to its own ClinicalTrials.gov record, which has the eligibility criteria and contacts.
| Title as registered | Registry ID | Status | Phase | Start | Institution and city |
|---|---|---|---|---|---|
| A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression | NCT07716098 | Recruiting | Phase 3 | 2026-08-03 | Janssen Research & Development, LLC, Taipei |
| Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression | NCT05045378 | Completed | Phase 4 | 2022-03-15 | Taipei Veterans General Hospital, Taiwan, Taipei |
| Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy | NCT03829124 | Status not reported | Phase 4 | 2019-05-24 | Chang Gung Memorial Hospital, Taoyuan District |
| Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide | NCT03666390 | Status not reported | Not applicable | 2018-09-10 | Taipei Veterans General Hospital, Taiwan, Taipei |
| Lamotrigine for Ketamine Dependence Trial | NCT02556060 | Completed | Phase 2 | 2015-09-01 | Taipei City Hospital, Taipei |
About this data
Compound tags come from automated matching of the registry search term and have not been checked record by record. Counts are of registered studies, not of people, results or approvals. A registry listing is not evidence of safety, benefit or results.
Substance hubs for these compounds
Condition hubs
Condition hubs that include studies counted in this country, with the number of those studies. Conditions are matched by keyword on registered titles, so one study can appear under more than one condition.
| Condition hub | Studies in this country |
|---|---|
| Depression | 3 |
| Treatment-resistant depression | 2 |
| Suicidal ideation and suicide risk | 1 |
Other country hubs
United States | Canada | Switzerland | United Kingdom | France | Israel | Brazil | China | Netherlands | Australia | Austria | Germany | Spain | Sweden | Argentina | Belgium | Egypt | Mexico | Poland | Ireland | Czech Republic | Denmark | Finland